Loader

Pathways

PathWhiz ID Pathway Meta Data

PW000006

Pw000006 View Pathway
metabolic

Alpha Linolenic Acid and Linoleic Acid Metabolism

Homo sapiens
Linoleic acid (LNA) is a polyunsaturated fatty acid (PUFA) precursor to the longer n−6 fatty acids commonly known as omega-6 fatty acids. Omega-6 fatty acids are characterized by a carbon-carbon double bond at the sixth carbon from the methyl group. Similarly, the PUFA alpha-linoleic acid (ALA) is the precursor to n-3 fatty acids known as omega-3 fatty acids which is characterized by a carbon-carbon double bond at the third carbon from the methyl group. Both LNA and ALA are essential dietary requirements for all mammals since they cannot be synthesized natively in the body. Both undergo a series of similar conversions to reach their final fatty acid form. LNA enters the cell and is catalyzed to gamma-linolenic acid (GLA) by acyl-CoA 6-desaturase (delta-6-desaturase/fatty acid desaturase 2). GLA is then converted to dihomo-gammalinolenic acid (DGLA) by elongation of very long chain fatty acids protein 5 (ELOVL5). DGLA is then converted to arachidonic acid (AA) by acyl-CoA (8-3)-desaturase (delta-5-desaturase/fatty acid desaturase 1). Arachidonic acid is then converted to a series of short lived metabolites called eicosanoids before finally reaching it's final fatty acid form.

PW088298

Pw088298 View Pathway
metabolic

Alpha Linolenic Acid and Linoleic Acid Metabolism

Rattus norvegicus
Linoleic acid (LNA) is a polyunsaturated fatty acid (PUFA) precursor to the longer n−6 fatty acids commonly known as omega-6 fatty acids. Omega-6 fatty acids are characterized by a carbon-carbon double bond at the sixth carbon from the methyl group. Similarly, the PUFA alpha-linoleic acid (ALA) is the precursor to n-3 fatty acids known as omega-3 fatty acids which is characterized by a carbon-carbon double bond at the third carbon from the methyl group. Both LNA and ALA are essential dietary requirements for all mammals since they cannot be synthesized natively in the body. Both undergo a series of similar conversions to reach their final fatty acid form. LNA enters the cell and is catalyzed to gamma-linolenic acid (GLA) by acyl-CoA 6-desaturase (delta-6-desaturase/fatty acid desaturase 2). GLA is then converted to dihomo-gammalinolenic acid (DGLA) by elongation of very long chain fatty acids protein 5 (ELOVL5). DGLA is then converted to arachidonic acid (AA) by acyl-CoA (8-3)-desaturase (delta-5-desaturase/fatty acid desaturase 1). Arachidonic acid is then converted to a series of short lived metabolites called eicosanoids before finally reaching it's final fatty acid form.

PW146486

Pw146486 View Pathway
drug action

Alpelisib Drug Metabolism Action Pathway

Homo sapiens

PW176373

Pw176373 View Pathway
metabolic

Alosetron Predicted Metabolism Pathway

Homo sapiens
Metabolites of Alosetron are predicted with biotransformer.

PW145067

Pw145067 View Pathway
drug action

Alosetron Drug Metabolism Action Pathway

Homo sapiens

PW145674

Pw145674 View Pathway
drug action

Alogliptin Drug Metabolism Action Pathway

Homo sapiens

PW132474

Pw132474 View Pathway
metabolic

Alogliptin Drug Metabolism

Homo sapiens
Alogliptin is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Alogliptin passes through the liver and is then excreted from the body mainly through the kidney.

PW145019

Pw145019 View Pathway
drug action

Almotriptan Drug Metabolism Action Pathway

Homo sapiens

PW176453

Pw176453 View Pathway
metabolic

Almitrine Predicted Metabolism Pathway

Homo sapiens
Metabolites of Almitrine are predicted with biotransformer.

PW145431

Pw145431 View Pathway
drug action

Almitrine Drug Metabolism Action Pathway

Homo sapiens